Skip to main content
HR 2298 114th Congress House Health Drug, alcohol, tobacco use Fraud offenses and financial crimes Government studies and investigations Health information and medical records Health technology, devices, supplies Medicare Prescription drugs

Medicare Patient Safety and Drug Abuse Prevention Act

Introduced: May 13, 2015 Introduced by: Bilirakis, Gus M. Republican · Florida See on congress.gov
This bill died when the 114th Congress ended
It never became law before the 114th Congress (2015–2016) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jun 1, 2015
Referred to the Subcommittee on Health.
May 15, 2015
Referred to the Subcommittee on Health.
May 13, 2015
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
May 13, 2015
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Medicare Patient Safety and Drug Abuse Prevention Act

Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act to authorize a prescription drug plan (PDP) sponsor to establish a drug management program for at-risk beneficiaries.

Requires a PDP sponsor, with respect to covered part D drugs, to have in place, directly or through appropriate arrangements, a utilization management tool designed to prevent: (1) the abuse of frequently abused drugs by individuals, and (2) the diversion of such drugs at pharmacies.

Directs the Department of Health and Human Services (HHS) to authorize Medicare drug integrity contractors (MEDICs) to accept directly an individual's prescription and necessary medical records from pharmacies, PDPs, and physicians in order for MEDICs to provide information relevant to determining whether the individual is an at-risk beneficiary.

Requires the Inspector General of HHS to study the effectiveness of MEDICs in identifying, combating, and preventing fraud under the Medicare program.

Expresses the sense of Congress that Medicare Advantage organizations and PDP sponsors should consider using e-prescribing and other health information technology tools to support combating fraud under MA-PD plans and prescription drug plans under parts C (Medicare+Choice) and D.

What's happening now June 1, 2015

Referred to the Subcommittee on Health.

 Related & companion bills 4
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 4
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 2298: Medicare Patient Safety and Drug Abuse Prevention Act. 114th Congress. Open America. https://openamerica.io/bill/114-HR-2298/
MLA
"H.R. 2298: Medicare Patient Safety and Drug Abuse Prevention Act." 114th Congress, 2026, Open America, https://openamerica.io/bill/114-HR-2298/.
Bluebook (legal)
H.R. 2298, 114th Cong. (2026), https://openamerica.io/bill/114-HR-2298/.
Markdown link
[H.R. 2298: Medicare Patient Safety and Drug Abuse Prevention Act](https://openamerica.io/bill/114-HR-2298/)
Report a problem